Hikal Ltd

NSE: HIKAL · BSE: 524735 · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹217.58
Market cap: ₹2,683 Cr
Revenue (annual): ₹1,713 Cr
Net profit (annual): ₹-48.80 Cr
P/E (TTM): -79.4×Sector 50.4×
Promoter holding: 68.85%+0.00% QoQ
FII holding: 0.98%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 2 Production Started 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

22 Sep 2026 13:38 IST BSE

Production Started

Hikal Production Started

Hikal has begun commercial production at its new cGMP Panoli facility, entering Personal Care manufacturing. First batches of UV filters and skincare ingredients are now being supplied to global customers.

Read the filing ↗